The present disclosure relates generally to replacement heart-valve technology, and more specifically to devices, systems, and methods for a collapsible and expandable heart-valve assembly that is highly flexible, resilient, retractable, and replaceable.
Heart-valve intervention, such as full open-heart surgery, is often required to treat diseases of one or more of the four heart valves, which work together to keep blood properly flowing through the heart. Replacement and/or repair of a heart valve is often required when a valve is “leaky” (e.g., there is mitral valve regurgitation) or when a valve is narrowed and does not open properly (e.g., mitral valve stenosis). Typically, heart-valve replacement, such as mitral-valve replacement, involves replacement of the heart's original (native) valve with a replacement, mechanical and/or tissue (bioprosthetic) valve.
Common problems with the replacement of valves and/or the frames carrying them comprise: degradation of the leaflets (valve-like structure); breaking or failing frames, particularly with laser-cut nitinol frames; and undesirable changing in size of the native valve annulus. Replacement heart valves pose additional problems after they are implanted. For example, the replacement valve may move or migrate after it is placed in a desired location in the heart, or its location may not permit proper directional flow of blood during delivery. Replacement valves are also not readily retrievable, most often because such removal can damage the surrounding heart tissue. This can be particularly problematic, for example, if the replacement valve is not properly and accurately placed into position when it is implanted in the native heart, as well as when the replacement valve starts failing, which may occur years after initial implantation. An additional problem is that typical replacement valves, especially laser-cut valve frames, are relatively stiff and inflexible, resulting in a valve that does not flex with the dynamic movements of the pumping heart. Such inflexible valves do not conform to such dynamic movements, which can cause trauma to the heart surfaces, cause breaks in the frame itself, otherwise cause or exacerbate problems during or after implantation.
Thus, what is needed are devices, systems, and methods for a replacement heart valve that enables compact and secure delivery into the desired location within the heart and convenient control of expansion and retraction of the heart valve when being implanted or removed, such as via a catheter. Such a replacement heart valve should provide adequate flexibility to match, conform to, or otherwise not impede the heart's dynamic movement. And it should ensure proper directional blood flow through the heart during and after the replacement procedure.
The following presents a simplified overview of the example embodiments in order to provide a basic understanding of some embodiments of the present disclosure. This overview is not an extensive overview of the example embodiments. It is intended to neither identify key or critical elements of the example embodiments nor delineate the scope of the appended claims. Its sole purpose is to present some concepts of the example embodiments in a simplified form as a prelude to the more detailed description that is presented herein below. It is to be understood that both the following general description and the following detailed description are exemplary and explanatory only and are not restrictive.
The present disclosure is directed to devices, systems, and method for a collapsible, replacement heart-valve assembly that is highly flexible, resilient, retractable, and replaceable. As disclosed herein, the valve assembly has the capability to be replaced years after implantation if problems, such as recurrent mitral valve regurgitation, arise.
In a preferred embodiment, a heart-valve system may comprise a tubular braided frame, wherein the tubular braided frame comprises an inflow end, an outflow end. The valve system may further comprise a leaflet assembly, wherein the leaflet assembly comprises at least one valve leaflet, wherein the at least one leaflet comprises an inflow end, an outflow end, and one or more commissure tabs extending horizontally away from the inflow end; and wherein the one or more commissure tabs of the at least one leaflet is connected to the one or more commissure posts of the tubular braided frame. In some embodiments, the tubular braided frame may comprise one or more commissure posts extending vertically away from the inflow end.
Still other advantages, embodiments, and features of the subject disclosure will become readily apparent to those of ordinary skill in the art from the following description wherein there is shown and described a preferred embodiment of the present disclosure, simply by way of illustration of one of the best modes best suited to carry out the subject disclosure. As will be realized, the present disclosure is capable of other different embodiments and its several details are capable of modifications in various obvious embodiments all without departing from, or limiting, the scope herein. Accordingly, the drawings and descriptions will be regarded as illustrative in nature and not as restrictive.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the disclosure and together with the general description of the disclosure given above and the detailed description of the drawings given below, serve to explain the principles of the disclosure. In certain instances, details that are not necessary for an understanding of the disclosure or that render other details difficult to perceive may have been omitted.
Before the present systems and methods are disclosed and described, it is to be understood that the systems and methods are not limited to specific methods, specific components, or to particular implementations. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting. Various embodiments are described with reference to the drawings. In the following description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of one or more embodiments. It may be evident, however, that the various embodiments may be practiced without these specific details. In other instances, well-known structures and devices are shown in block diagram form to facilitate describing these embodiments.
Disclosed herein is a collapsible heart-valve assembly system comprising at least a braided, collapsible frame and leaflet assembly that together serve to provide a sealing portion. The valve assembly may be delivered through a catheter and may perform as either a standalone valve replacement or placed within an existing receiver structure. The valve assembly may further comprise attachments and additional features for catheter delivery, positioning, partial deployment, and retrieval.
The valve assembly 100 may further comprise one or more tabs 130, wherein the tabs 130 are sewn to the commissure posts 140. The valve assembly 100 may also comprise a base stitch 150 along a row of lashed crossing points of the frame 110, wherein the base stitch 150 connects the frame 110 to the leaflet assembly 120 along the circumference of the leaflet assembly's centerline 160. A base stitch 150 may be defined as the stitching line that delineates the inflow edge of a functional valve assembly 100.
Thus, as shown in
The valve assembly disclosed herein is novel and an improvement over the prior art because it combines a minimal braided, wire structure with a novel leaflet-assembly design, wherein the integration of both together in a strategic manner provides a valve that may be compressed to a very low profile that is much smaller than other existing percutaneously delivered valves. Additionally, the design of the valve assembly creates an option for ease of removal, either by percutaneous techniques or by minimally invasive surgical techniques.
Benefits of this disclosure over prior art include but are not limited to a less-invasive and less-traumatic puncture to accommodate delivery of the valve assembly. Further, the profile of the valve assembly and the strategic combination of wire-braid frame, leaflet assembly, and attachment strategy allows for a more flexible delivery system. This is due to the nature of the flexible wire frame and because the valve is relatively short and allows for flexibility in the delivery catheter. The combination of these factors allows for less traumatic delivery, more precise delivery, and a greater number of options on how to deliver.
Additionally, the ability to remove by percutaneous or minimally invasive techniques is a unique advantage of this valve assembly. Current state-of-the-art implanted valves, if they become malfunctioning or disabled, must either be removed by major surgical techniques or by implanting a second valve inside the malfunctioning valve. Both of these options have major drawbacks. Major surgery often is obviated by a patient because of age or physical condition. And implanting a valve inside an existing valve compromises the newly implanted valve and reduces the options if it does not work as intended.
Thus, the present systems, devices, and methods disclosed herein include replacement heart valve frames that are highly flexible, resilient, retractable, and replaceable—including replacement years after implantation if problems such as recurrent valve regurgitation arise.
In one embodiment, the replacement heart valve system comprises: a retrievable frame portion holding a replacement heart valve (i.e., a blood flow regulator such as an array of valve leaflets, a porcine valve leaflets, or other structure that selectively allows/prevents flow of blood through the valve, typically unidirectional); and a receiver frame portion sized and configured to removably retain the retrievable frame portion. Both of the frame portions can advantageously be made of braided nitinol, although other materials can also be used such as stainless steel, cobalt chrome, polymers such as nylon, or laser-cut nitinol. The tissue leaflets, or other blood flow regulator, are constructed to perform the function of a valve to regulate flow through any one of the four orifices in the human heart, including for example the mitral valve, although the system can also be configured for and used/located in the tricuspid valve, the pulmonary valve, or the aortic valve.
The frame portions of the replacement heart valve systems herein, particularly the retrievable frame portion, can be made of a single (or multiple) wire braid. Such frame portions can be constructed, for example, using nitinol wire on a cylindrical mandrel, following an over-under configuration of wire wraps. Where the frames are made of nitinol or other shape-memory material, the frames can be shape-set to produce a stress-free structure after it is expanded in situ. Some advantages of wire-braid frames, for certain situations, is that such wire-braid frames can be constructed such that they are substantially stress-free both when deployed as well as when they are contained and constrained within a delivery or retrieval catheter; except for apical vertices of the frame located at the inflow and outflow ends of the frame, which are bent inwardly due to such in-catheter disposition.
The cardiac valve retrievable frame houses valve leaflets or other unidirectional valve structure. Leaflets can be cut from bovine pericardium (or other materials) and sewn, fused or otherwise attached together along edges and attached to the frame along the inflow edge of the structure.
The replacement heart valve system including each and both of the retrievable frame portion and receiver frame portion, has an inflow end and an outflow end. Inflow references the end of the frame/system that blood flows into the frame/system, while outflow references the end of the frame/system that blood flows out of the frame/system. For example, when the frame/system is deployed in the mitral valve, the outflow end is located in the left ventricle while the inflow end is located in the left atrium.
The frame portions of the heart valve system can be provided separately or as a unit. For example, the retrievable frame portion and receiver frame portion can be surgically implanted or carried in a catheter—either linked together or separately in a single catheter, or separately in separate catheters. The retrievable frame portion and receiver frame portion, both separately and particularly when provided in a single catheter, can be compressed to catheter dimensions as desired, for example as small as 26F, 24F, 18F, 16F, 14F or less. The replacement heart valve system typically provides one-way flow control.
During deployment of the replacement heart valve system, one or both ends of the system is configured to retain mechanical connection with the catheter delivery system such that the replacement heart valve system can be positioned and repositioned through physical motions such as rotation and translation, or a combination thereof. Once fully released from the delivery catheter, the replacement heart valve system secures the receiver frame portion of the system to the target native heart, for example via expansion and/or self-expansion to create a radial force against tissue at the target site, anchoring elements that connect to the target tissue, or otherwise as desired. Such securement contact typically includes contact with the target native heart valve, such as the native heart valve leaflets and annulus, and/or native heart structures on either the inflow and/or outflow sides of the native heart valve. In an embodiment, the receiver frame portion and/or the retrievable frame portion have a cross-section that is generally cylindrical or D-shaped to fill the target orifice. The retrievable frame portion and receiver frame portion may have compatible or identical cross-sectional shapes so that the retrievable frame portion nests within the receiver frame portion.
In some embodiments, the retrievable frame portion and the receiver frame portion are cooperatively sized and configured together to fit together within a single heart catheter for delivery to a target mitral valve or other target location. The retrievable frame portion and the receiver frame portion can be carried in the delivery catheter as a single unit, i.e., in an as-connected form where the two portions are mechanically linked together. This configuration can advantageously allow the delivery catheter to control both portions of the frame system by controlling only one of the frames, for example using the proximal frame portion to control the distal frame portion (the distal frame portion being the frame portion that first exits the end of the delivery catheter).
The retrievable frame portion and the receiver frame portion can also be carried in the delivery catheter in an unconnected form where the two portions are not mechanically linked together. This configuration can advantageously allow the delivery catheter to independently control each of the frame portions and can also increase the flexibility and torsion characteristics of the delivery catheter containing the frames, which can be advantageous both while conveying the delivery catheter to through the patient's body, the vasculature, the desired target, and while delivering the replacement valve at/to the target.
In some embodiments, the retrievable valve frame portion and the receiver frame portion can each be less than about 50 mm, 40 mm, 30 mm, or 25 mm in length.
In certain embodiments, the frame portions can bend to a radius of curvature as low as about 1″, ¾″, ½″, ⅜″, or ¼″ (inches).
In some methods of deployment, the two frame portions can be carried in unconnected format, then mechanically connected to each other while at least a substantial portion of one of the frames (typically the distal frame) has been pushed or otherwise thrust into the target heart, including into the target location within the heart.
These methods can take advantage of the benefits of separated-frame carriage within the delivery catheter while also taking advantage of the ability to control both (or more, if more than two) frame portions via only a single-frame connection with the delivery catheter's control elements. This can also advantageously allow partial deployment then manipulation (even full withdrawal) of the frame system to deploy the receiver frame portion in a better location in the target heart location, or even full deployment then manipulation/withdrawal of the frame system to a more desired location, orientation, etc., at the target location.
After full deployment of the replacement heart valve system in a target location, the retrievable frame portion is removably retained within the receiver frame portion such that removal of the retrievable frame portion from the receiver frame portion comprises gathering and pulling the retrievable frame portion from the receiver frame portion, twisting and pulling the retrievable frame portion from the receiver frame portion, twisting and pushing the retrievable frame portion out of the receiver frame portion, or otherwise as desired. The retrievable frame portion is typically withdrawn from the receiver frame portion without substantially disturbing or disrupting the connection of the receiver frame portion to the target location in the heart, and without harming the native heart tissue. For example, removal of the retrievable frame from the receiver frame does not dislodge replacement valve tissue, target tissue, nor frame elements during such removal as well as during re-insertion of a new valve and retrievable frame assembly. Exemplary forces to remove the retrievable frame from the receiver frame include less than 1.5 pounds, less than 1 pound, less than 0.75 pounds, less than 0.5 pounds or less than 0.25 pounds.
The retrievable frame portion retained within the receiver frame portion can have a high degree of flexibility. In certain embodiments, the retrievable frame portion is substantially more flexible than the receiver frame portion. The retrievable frame portion and/or receiver frame portion can be made of braided wire. The braided wire can be nitinol or stainless steel or other material as desired.
In some embodiments, the retrievable frame portion and the receiver frame portion can be cooperatively sized and configured to a) removably retain the retrievable frame portion in the receiver frame portion against blood flow forces in a heart valve holding the replacement heart valve system and b) release the retrievable frame portion from the receiver frame portion without harming surrounding target heart tissue. The heart valve can be a mitral valve or other target heart valve. The native heart tissue can be native heart valve tissue.
The retrievable frame portion and the receiver frame portion can be cooperatively sized and linked to fit within a single heart catheter for delivery to a target mitral valve. The retrievable frame portion can be retained within the receiver frame portion such that removal of the receiver frame portion from the receiver frame portion can comprise pushing or pulling the retrievable frame portion through the receiver frame portion towards an inflow end of the receiver frame portion. The retrievable frame portion can be retained within the receiver frame portion such that removal of the receiver frame portion from the receiver frame portion can comprise pushing or pulling the retrievable frame portion from the receiver frame portion towards an outflow end of the receiver frame portion. The retrievable frame portion can be configured such that the retrievable frame portion substantially does not touch a side of a native heart chamber when the retrievable frame portion is placed in the native heart chamber.
Intersections of the braided wire comprise crossing angles of 20° to 30° in a fully expanded configuration or crossing angles of about 0° to 5° in a fully compressed configuration such that compressed wires are substantially parallel to each other. Crossing angles within the retrievable frame portion or the receiver frame portion can be uniform or non-uniform.
Apical angles of the braided wire are 20° to 30° in a fully expanded configuration, or 160° to 180° in a fully compressed configuration such that the wire leading into and out of the apex is substantially parallel to itself. Apical angles within the retrievable frame portion or the receiver frame portion can be uniform or non-uniform.
A combination of the retrievable frame portion within the receiver frame portion together has a flexibility such that the combination can bend to a radius of curvature less than about 1″, ¾″, ½″, ⅜″, or ¼.″
Thus, methods can comprise: During the implanting, removing the retrievable frame portion from the receiver frame portion and re-inserting retrievable frame portion into the receiver frame portion. The methods can also comprise: After the implanting is completed, accessing only via catheter the replacement heart valve system as located in the target heart valve and removing the valve and retrievable frame assembly from the receiver frame portion. Such methods can further comprise: After removing the valve and retrievable frame assembly from the receiver frame portion, replacing the valve and retrievable frame assembly in the receiver frame portion with a second, different valve and retrievable frame assembly.
These embodiments enable facilitation of the replacement of a heart blood flow regulator, such as a tissue valve, after initial placement, without excessive harm to any of the patient's body, heart or target heart valve. This is highly advantageous because replacement valves often suffer problems that require replacement of the heart valve. Common problems with replacement valves and/or the frames carrying them include the leaflets can degrade, the frames can break or otherwise fail, particularly with laser-cut nitinol frames, and the native valve annulus can undesirably change in size. The current systems, etc., reduce or even eliminate one or more of these problems.
In some embodiments, commissure posts can be provided on a “free end” of the retrievable frame portion, which means the end of the retrievable frame portion that is not connected to the receiver frame portion. The commissure posts can be configured to anchor the leaflet tissue, for example three commissure posts can be disposed at substantially equidistant locations around the receiver frame portion to provide connection locations for each commissure of a three-leaflet valve. If the commissures of the three-leaflet valve are not equidistant, then the commissure posts of the valve frame can be configured to match the locations of such valve commissures. In another example, two commissure posts can be used for a bi-leaflet valve. Other valve-commissure post orientations and configurations can also be provided, including that the number of commissure posts does not have to equate to the number of leaflets. Such commissure posts can provide anchoring points to hold the leaflets or other unidirectional valve structure and can also provide deployment attachment points for the delivery and/or retrieval catheter.
Attachment of the leaflets can also be made to a cuff carried by the retrievable frame, or other materials can be provided to create a sealing zone at the inflow end to prevent the flow of blood between the retrievable frame structure and the receiver frame, which can be cylindrical. Gripping, positioning, securement, and retrieval elements such as grippers, positioners, anchors, or retrieval hooks can be included in the retrievable frame portion and receiver frame portions. Such securement elements permit a physician or other user to accurately place the structure in a target heart valve and to easily retrieve the retrievable frame structure post-deployment if desired. Exemplary methods to implement such easy, low-impact removal include known heart procedures such percutaneous access, for example via catheter under fluoroscopy.
In some embodiments, the retrievable frame portion, for example when made of braided wire, can be configured to be inserted into a primary receiver frame portion that is the initial frame of the replacement heart valve system to be implanted into the target site; this receiver frame portion may be permanently implanted. The retrievable frame valve assembly is then implanted or inserted as a secondary portion of the replacement heart valve system; this retrievable frame portion/valve and retrievable frame assembly may not be permanently implanted but instead can be easily withdrawn and replaced, in some embodiments without harm to the target native heart tissue. This receiver frame portion is typically configured to be permanently implanted into the native target site, while the valve assembly (i.e., an assembly comprising the blood flow regulator valve and the retrievable frame portion) is configured to be removable, for example by a catheter procedure, for up to several or more years after implant. The system of the braided wire retrievable frame portion and receiver frame portion can thus be configured so that they work in concert to connect to the cardiac tissue, hold tissue valve leaflets in place to control blood flow, and be strong enough to resist the forces of cardiac blood flow, yet also allow replacement of the replacement tissue valve and/or the valve and retrievable frame assembly easily and without damaging the native heart.
This division into separated entities can also allow the valve frame, i.e., the retrievable frame portion, to be constructed with a lighter wire than if the full valve system were one piece. Exemplary embodiments of such lighter wire include nitinol wire from 0.009″ to 0.015″ diameter. One advantage of such systems is that the lighter secondary/retrievable valve portion can be compressed more than a stiffer frame and thus the secondary/retrievable valve portion can be delivered in and retrieved by a smaller catheter. This also allows a greater range of patients to receive the treatment.
Another advantage of the current braided wire frames is that, when compressed to catheter dimensions, the retrievable frame portion experiences significant strain values, including peak strain values, only in the frame apices at either end of the retrievable frame. In contrast, typical percutaneous replacement valves with rows of zig-zag features experience large outward strains along the full length of the structure. Thus, the current braided wire frames allow for a smaller bend radius of curvature (less than 0.75″, 0.5″, etc.), less force and torque required for positioning/repositioning the retrievable valve frame, and the ability to “stack” several structures (e.g. a receiver/anchor system along with the valve structure) into a single catheter for a rapid sequential deployment. Another advantage of the current braided wire frames is greater positional accuracy and ease of repositioning, for example because of the reduced outward force profile of the frames herein.
The wire(s) of the braid can move or slide independently of each other at each crossing. This slippage allows for a high degree of design and configuration options so that a user can configure a replacement heart valve system, including individual portions and parts thereof, for specific situations such as specific patients or target sites. The strength of the braided frame can be selected by providing a specific, desired number of wraps and/or configurations of the wire(s). Exemplary outward radial forces exerted by the frame portions herein when deployed at a target location include at least about 0.15 N, 0.2 N, 03 N, and 0.4 N. Exemplary outward radial forces exerted by the frame portions herein when deployed at a target location include about 1 N, 1.5 N, and 2 N.
If desired, the wraps can be braided in a zig zag pattern and braid angle. Examples of such braid angles where the braided wires cross each other include crossing angles of 15°, 20°, 30° or 45° in the as-deployed configuration. Examples of such braid angles where the braided wires cross each other include about 0° to 5° in the compressed (in-catheter) configuration such that the crossing wires are substantially parallel to each other. Such braid-crossing angles can be uniform throughout the frame or can be non-uniform for example to implement differential braid/frame resiliencies or radial pressures in different locations within a frame.
A radial force is created by each bend, or “elbow,” in the apexes in the wire structure. Thus, the frames can be precisely configured for specifically desired forces such as radial forces that help keep the valve and retrievable frame assembly expanded properly and housed in the receiver frame, or to allow proper support of leaflet function, by selecting a desired number of wraps. Forces exerted by the wire braid can also be configured by selecting or modifying a combination of parameters such as wire diameter, “elbow” angles, number of wire crossings, and zig zags around the circumference of the frame. This allows for selected configuration of the frames for specific performance criteria such as valve closing forces, delivery forces, deployment forces, and retrieval forces. Exemplary apice or elbow angles in the compressed form (in-catheter) of the frame include about 160° to 180° such that the wire leading into and out of the apex is substantially parallel to itself. Exemplary apice or elbow angles in the as-deployed form (expanded configuration) of the frame include about 60°, 70°, 80°, to 90°. Such apex angles can be uniform throughout the frame, or can be non-uniform; for example, either different apical angles from one apex to the next, or by having different angles within a single apex. Non-uniform apical angles can help to implement differential braid/frame resiliencies or radial pressures in different locations within a frame.
Releasable gripping and locking elements can be integrated into the frames to provide desire manipulation, control, and anchoring of the retrievable frame to a previously placed receiver.
In some embodiments, the unidirectional blood-flow regulator contains tissue leaflets, which contribute moveable surfaces that are biocompatible, durable, and capable of opening and closing, with a finite region of coaptation to seal off and prevent blood flow. The leaflets can be attached to each other, for example, through sewing with suture material and/or tissue welding. Tissue and fabric materials for the leaflets can be chosen to control tissue ingrowth and endotheliazation, for example to selectively promote or inhibit tissue ingrowth and endotheliazation, so that the retrievable frame portion can be fully removed post-deployment. Frame materials, including combinations of frame materials, can also be chosen and configured to control tissue ingrowth/endotheliazation.
Securement elements such as loops, hooks, sutures and the like, as well as combinations thereof, configured to remove the retrievable frame portion post-deployment are configured so that the retrievable frame portion, typically including the valve carried therein, is drawn down to a smaller size such that the retrievable frame portion can be withdrawn from the receiver frame portion. As one example, the retrievable frame portion can be drawn down to one-half its fully expanded diameter. The retrievable frame portion can then be remotely compressed further if desired, for example down to 20-30% of full diameter. The retrievable frame portion can then be pulled into a catheter or sheath, for instance a 24F sheath, permitting the entire structure to be pulled into a catheter for removal from the target valve site. Such removal can be effected transapically, transseptally, transaortically, or otherwise as desired. Exemplary removal elements include a string or wire that resides in situ in the retrievable frame portion while it is deployed in the target site, which string can be snared be a retrieval catheter and the twisted or otherwise used to draw down or lessen the diameter of the retrievable frame portion so that the retrievable frame can be pulled through or pushed from the receiver frame portion for removal and replacement. This can reduce the overall force used to push/pull the device out of the receiver frame portion and into a removal sheath in the retrieval catheter.
A belly stitch is defined as a stitch originating at the edge seams of the Z-valve insert and following a wire to define an edge of a leaflet, with the option to attach to one of the wires of the frame and/or cuff. The wire where the belly stitch is attached may be shaped-set to further improve leaflet durability and performance. A cuff may be defined as additional material positioned either on the outside or inside of the frame and may be extended along the top and bottom of the frame, though at a minimum is attached above and below the base stitch. The belly stitch serves the purpose of improving leaflet durability and hemodynamic performance. A valve belly stitch 850 is angled from the distal outer sections towards the middle center of the leaflet and may, in one embodiment, either be sewn to the braided frame or an outer cuff. A bellows portion 860 creates the bottom of the belly and may or may not be sewn to the frame. A bellows portion 860 of the belly stitch 850 may be defined as an interruption of attachment or following of the belly stitch, generally at the center of the leaflet, that serves to improve collapsibility.
In another embodiment, a continuous cuff may be sewn to the Z-valve insert at the baseline stitch location and wrapped around the inflow edge of the braided valve frame to become a cuff on the outer side of the frame. And in a separate embodiment, a valve may have both an inner cuff and an outer cuff, and/or partial cuffs that cover discrete portions of the braided valve frame.
Cuffs 1610 are generally used for covering the wires of the frame so as to provide a sealing zone, wherein a sealing zone, or ring, is formed to prevent blood flow from either side while the leaflets provide flow control. The sealing zone is comprised of either flexible or non-flexible material. Cuffs 1610 also serve the purpose of attaching the Z-valve insert to the frame. In a preferred embodiment, the cuff 1610 attached along the top and bottom edges of the frame, or along a row of crossing points. A cuff 1610 may be attached to the frame along all adjacent wires, such as with a stitch that does not interfere with the motion of the braid crossing points.
In one embodiment, the leash, also referred to as a capture string, is threaded in a complete circle around the inflow end of the retrievable frame. The leash 1910 may be threaded around commissure posts and through wire elbows. The leash 1910 can be used to retrieve the valve by the retrieval catheter. For example, the leash 1910 can be captured by a retrieval catheter and put in tension (i.e., pulled on) radially inwardly, which in turn pulls the frame inward radially and thus away from the permanently implanted receiver frame portion. Also shown in
In a preferred embodiment, a corset 2720 is rectangle- or square-shaped and made of a non-compliant fabric, such as dacron, ripstop nylon, or similar fabrics. The fabric of the corset 2720 comprises a strong, tight weave, non-compliant in both x and y directions, with a thickness that may range 0.002-0.006″ (inches) and corresponding weights. The fabric of the corset 2720 may be formed into a tube, such that the meeting ends of the fabric are in close proximity but not overlapping. The meeting ends may have alternating stitches 2730—termed, releasing sutures—that loop around a pull wire 2740 and back in a manner that, when in place, the pull wire 2740 keeps the meeting ends together, and when the pull wire 2740 is pulled out through the releasing sutures, the meeting ends are released and separate. In some embodiments, the pull wire 2740 may be configured to attach to a portion of the corset 2720 for retrieval after the wire is pulled though the releasing sutures. Pull wires may comprise bent ends to prevent accidental removal during assembly. Upon fmal assembly, the bends at the ends of the pull wires are snipped off.
Pull wires 2740 may be constructed of very flexible stainless steel or nitinol, typically 0.010-0.020″ in diameter, and coated with friction-reducing coatings such as teflon, paralene, silicone, or the like. The pull wires 2740 may be translated from the distal end of the catheter where the valve assembly is, to the proximal end of the delivery catheter that employs a handle for controlling the catheter and securing/releasing the pull wires 2740 and retrieval leashes 2750. The catheter may employ a single lumen through which all the wires and leashes translate, it may have multiple lumens for each wire and leash, and it may comprise combinations thereof. Where the delivery system employs a larger guide catheter that the delivery system translates through, the released corsets can be pulled into this guide using the leashes and subsequently removed. The combination of the corset and pull wires provide the benefit over prior art of a release system wherein the forces to pull the wires are very small and can be done easily around a 180-degree turn, and so displacement of the catheter and valve is minimized.
In other embodiments, a guiding catheter may be placed in the patient's body first, then the rails, which can be separate from or releasably attached to receiver frame portion either in the guiding catheter or in the target site, are placed through the catheter into the target site. The anchors are engaged to desired cardiac structures such as the chordae tendineae. Next, the receiver frame portion is placed through the guiding catheter after the proximal ends of the delivery guiding rails are threaded through collars on the receiver frame portion, the receiver frame portion attached to the anchors and thus placed at the desired target native cardiac structure location. The receiver frame portion is then released from the receiver delivery guiding catheter, which catheter then is withdrawn from at least the heart, and typically the body, of the patient. The anchors are then released from the rails, and the rails are withdrawn. Subsequently, a valve delivery catheter is placed in the guiding catheter and the valve and retrievable frame assembly is delivered to and connected to the receiver frame portion, for example by inserting valve and retrievable frame assembly partially or completely into the receiver frame portion and/or mechanically attaching the valve and retrievable frame assembly to the receiver frame portion.
In other embodiments, the replacement heart valve systems can also be implemented and/or used as follows: The rails and anchors are translated percutaneously across the target heart valve. A sheath carrying the rails and to implement anchors through the guiding catheter is pulled back partially to expose the hook of the anchor, and the hook is then manipulated to engage the valve chordae and/or other sub-valvular structure (depending in part on the target valve). Once the hooks are satisfactorily engaged in the target site, the receiver frame portion, which is configured to hold a retrievable frame portion, is loaded onto the rails and slid into place such that the mating features on the receiver frame portion are properly located on corresponding mating zones of the anchor. The receiver frame portion is then expanded. Once expanded, the receiver and anchors combine to be essentially one complete anchor/receiver unit, i.e., an in-situ anchor-receiver frame unit. The anchors are then released from the delivery guiding catheter by disengaging the wire lock from the torque tube and pulling proximally. The valve and retrievable frame assembly is then delivered through the same or a different catheter and attached in situ to the anchor/receiver unit.
The embodiments depicted above are not limiting. Other delivery mechanisms are possible, including for example combining the receiver frame portion and the valve and retrievable frame assembly into one delivery catheter, combining the rail/anchors and the receiver frame portion into one delivery catheter, or various combinations of the above.
In other embodiments, frame-variations comprise a suitable apex-bend radii at the time of manufacture (for when the frame is being constructed on a mandrel) of a retrievable frame portion include an internal radius of 0.2 mm, 0.3 mm, 0.4 mm, or 0.5 mm. Such radii can be reduced to 0.1 mm or less when the frame is collapsed to in-catheter configurations.
Suitable materials to construct the frames, leashes, coatings, etc., herein can be selected and configured as desired or needed by a user or patient. For example, material coverings or coatings can be selected and configured to elicit specific cellular and molecular responses, such as endotheliazation promotors that promote endothelial coverage of the frame, anchors. Other coatings, etc., can be selected to enhance biocompatibility but inhibit or eliminate tissue ingrowth/integration. This endotheliazation inhibition can enhance the ability of a device herein to be removed from a target site while breaking minimal adhesions, i.e., cellular connections, between the frames herein or between the frames and the target tissue. Examples of pro-endotheliazation agents include), and pro-VEGF factors. Examples of anti-endotheliazation agents include medically acceptable fucans and anti-VEGF drugs such as bevacizumab (monoclonal antibody); ranibuzumab (antibody derivative); pegaptanib (aptamer); lapatinib, sunitinib, and sorafenib (oral small molecule agents that inhibit tyrosine kinases); VEGF trap-eye (fusion proteins), and miscellaneous agents such as siRNA-bevasiranib and adPEDF.
In some embodiments, pro-bioactivity and anti-same-bioactivity agents are provided on different, selected areas of the devices, systems, etc., herein, including for example with a single frame. For example, a pro-endothelization agent can be provided in one location and an anti-endothelization agent provided in another location. The agents' locations can be configured, for example, to enhance in-growth of permanent elements such as anchors or connection native-tissue elements of receiver frames (if any) while enhancing free movement or easy removal of non-native-tissue-connection elements. Native tissue responses can also be affected by a user's choice of material or coating properties including but not limited to chemistry/composition, structural dimension, pore size, and surface topography.
In other embodiments, the materials of the valve system can be inert or can have a controlled or predictable reactivity with or to surrounding native tissue. Reactivity mechanisms can be selected to elicit cellular reactions such as promoting endothelial attachment of the native target site to permanently implanted portions of the replacement heart valve system, thereby promoting biocompatibility. In some embodiments, reactivity mechanisms of the frame material and/or its coatings can be selected to elicit moderate-to-aggressive tissue ingrowth integrating the material into the native tissue such as native myocardium. In some embodiments, reactivity mechanisms of the frame material and/or its coatings can be selected to suppress specific reactions such as thrombosis or inflammation/scarring. One example of such an anti-scarring/anti-fibrous adhesion material is medically acceptable fucan.
Coatings and other materials can also be selected to promote biocompatibility. Suitable coatings include polymers and chemical vapor deposited ceramics such as low temperature isotropic carbon. Coatings and other materials can include drugs having a selected, specific therapeutic effect. Fabric-type materials can be a fabric of woven, braided, knit, etc. Materials can also form a film or sheet, such as a polymer film, that spans between supporting members, or struts. One example of a suitable material is ePTFE, including ePTFE having a selected, desired porosity.
Physical characteristics of the frame can include a time-dependent response such as one frame portion of the device deploying to final configuration more slowly relative to another frame portion of the device to ensure proper sequence of actions. Such time-dependent response can be varied between the retrievable frame portion and receiver frame portion, or within different sections of a single frame.
Materials in and/or between the frame(s) of the delivery system can also be selected and configured to assist in deployment/retrieval of the device. One example of such a configuration is to place material between deployment or control wires extending from the catheter to create an “umbrella” that modulates blood flow during delivery. Materials such as fabrics can be advantageously used in such configurations, or to provide physical support or restraint of frame members relative to one another, or to attach leaflets.
Additional desirable characteristics can include selected lubricity of the components, for example by providing a Teflon material, so that lubricity between the frames, or the system herein against the interior of the delivery catheter(s), is increased, and thus friction decreased, to reduce the force to deploy the device. This can also improve tactical feedback to the surgeon or other user.
Properties of the materials, etc., herein, including for example coatings, fabric, and tissue, may be varied in localized areas of the device including within the valve leaflets, within a frame or between one frame and the next. For example, a material can be configured elicit a reaction of tissue ingrowth that diminishes from one part of the structure relative to another—such as moving inward radially. Similarly, coatings can be removed or selectively deposited to vary the characteristics of a localized area of the device.
Other embodiments may include combinations and sub-combinations of features described or shown in the several figures, including for example, embodiments that are equivalent to providing or applying a feature in a different order than in a described embodiment, extracting an individual feature from one embodiment and inserting such feature into another embodiment; removing one or more features from an embodiment; or both removing one or more features from an embodiment and adding one or more features extracted from one or more other embodiments, while providing the advantages of the features incorporated in such combinations and sub-combinations. As used in this paragraph, “feature” or “features” can refer to structures and/or functions of an apparatus, article of manufacture or system, and/or the steps, acts, or modalities of a method.
References throughout this specification to “one embodiment,” “an embodiment,” “an example embodiment,” etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include that particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with one embodiment, it will be within the knowledge of one skilled in the art to affect such feature, structure, or characteristic in connection with other embodiments whether or not explicitly described.
Unless the context clearly indicates otherwise (1) the word “and” indicates the conjunctive; (2) the word “or” indicates the disjunctive; (3) when the article is phrased in the disjunctive, followed by the words “or both,” both the conjunctive and disjunctive are intended; and (4) the word “and” or “or” between the last two items in a series applies to the entire series.
Where a group is expressed using the term “one or more” followed by a plural noun, any further use of that noun to refer to one or more members of the group shall indicate both the singular and the plural form of the noun. For example, a group expressed as having “one or more members” followed by a reference to “the members” of the group shall mean “the member” if there is only one member of the group.
The term “a” or “an” entity refers to one or more of that entity. As such, the terms “a” (or “an”), “one or more” and “at least one” can be used interchangeably herein. It is also to be noted that the terms “comprising”, “including”, and “having” can be used interchangeably.
This application claims benefit to U.S. Provisional Application No. 63/015,353, filed on Apr. 24, 2020, titled Devices, Systems and Methods Relating To Quickly Implantable and Replaceable Heart Valves; and claims benefit to U.S. Provisional Application No. 63/025,881, filed on May 15, 2020, titled Devices, Systems, and Methods For a Collapsible and Expandable Replacement Heart Valve; the contents of all of which are incorporated herein by this reference as though set forth in their entirety, and to which priority and benefit are claimed.
Number | Date | Country | |
---|---|---|---|
63015353 | Apr 2020 | US | |
63025881 | May 2020 | US |